BRAF and melanoma: Only MET and GAB1 exhibited significant induction following vemurafenib or PD0325901treatment (Figure 4A), indicating this induction may contribute to the underlying mechanism of HGF rescue and explain the unique ability of HGF to rescue BRAF mutant melanoma cells from MAPK pathway inhibition.